Home
>
Inhibitors/Agonists>Cell Cycle>Nucleoside Antimetabolite/Analog> N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide
For research use only. Not for therapeutic Use.
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propane-2-yl)amino]phosphanyl]oxy-3-(2-methoxy ethoxy)oxolan-2-yl]purin-6-yl]benzamide (Cat No.:L015922) is a highly complex chemical compound with a benzamide group linked to a purine ring, forming a part of an extensive sugar-phosphate backbone. The molecule’s intricate structure suggests potential applications in pharmaceutical research, possibly involving interactions with biological processes associated with purine derivatives.
Catalog Number | L015922 |
CAS Number | 251647-53-7 |
Molecular Formula | C50H58N7O9P |
Purity | ≥95% |
Target | Nucleoside Antimetabolite/Analog |
IUPAC Name | N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide |
InChI | InChI=1S/C50H58N7O9P/c1-34(2)57(35(3)4)67(64-28-14-27-51)66-44-42(31-63-50(37-17-12-9-13-18-37,38-19-23-40(60-6)24-20-38)39-21-25-41(61-7)26-22-39)65-49(45(44)62-30-29-59-5)56-33-54-43-46(52-32-53-47(43)56)55-48(58)36-15-10-8-11-16-36/h8-13,15-26,32-35,42,44-45,49H,14,28-31H2,1-7H3,(H,52,53,55,58)/t42-,44-,45-,49-,67?/m1/s1 |
InChIKey | VPBYBQBHLYRLHG-HDMAWCRFSA-N |
SMILES | CC(C)N(C(C)C)P(OCCC#N)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC |